Position in VIR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$17,937,920
New position
Shares Held
2,002,000
first reported quarter
Ownership
1.19%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Soleus Capital Management, L.P. holds $1,377,926,098 across 59 Biotechnology names. VIR ranks #17 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
|
1,153,087 | $297,865,433 | |
| 2 | CELC |
Celcuity Inc.
|
1,284,378 | $146,598,904 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
4,029,319 | $133,853,977 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
330,517 | $106,489,272 | |
| 5 | VCEL |
Vericel Corp
|
2,549,079 | $82,003,871 | |
| 6 | GERN |
Geron Corp
|
41,508,659 | $61,847,901 | |
| 7 | EWTX |
Edgewise Therapeutics, Inc.
|
1,449,915 | $45,672,322 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
131,650 | $43,559,035 |
All Filings in VIR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,937,920 | 2,002,000 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||